Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
03 10 2023
Historique:
accepted: 12 01 2023
received: 15 09 2022
medline: 5 10 2023
pubmed: 22 2 2023
entrez: 21 2 2023
Statut: ppublish

Résumé

Trained immunity (TI) is a de facto memory program of innate immune cells, characterized by immunometabolic and epigenetic changes sustaining enhanced production of cytokines. TI evolved as a protective mechanism against infections; however, inappropriate activation can cause detrimental inflammation and might be implicated in the pathogenesis of chronic inflammatory diseases. In this study, we investigated the role of TI in the pathogenesis of giant cell arteritis (GCA), a large-vessel vasculitis characterized by aberrant macrophage activation and excess cytokine production. Monocytes from GCA patients and from age- and sex-matched healthy donors were subjected to polyfunctional studies, including cytokine production assays at baseline and following stimulation, intracellular metabolomics, chromatin immunoprecipitation-qPCR, and combined ATAC/RNA sequencing. Immunometabolic activation (i.e. glycolysis) was assessed in inflamed vessels of GCA patients with FDG-PET and immunohistochemistry (IHC), and the role of this pathway in sustaining cytokine production was confirmed with selective pharmacologic inhibition in GCA monocytes. GCA monocytes exhibited hallmark molecular features of TI. Specifically, these included enhanced IL-6 production upon stimulation, typical immunometabolic changes (e.g. increased glycolysis and glutaminolysis) and epigenetic changes promoting enhanced transcription of genes governing pro-inflammatory activation. Immunometabolic changes of TI (i.e. glycolysis) were a feature of myelomonocytic cells in GCA lesions and were required for enhanced cytokine production. Myelomonocytic cells in GCA activate TI programs sustaining enhanced inflammatory activation with excess cytokine production.

Identifiants

pubmed: 36802235
pii: 7048659
doi: 10.1093/rheumatology/kead061
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3469-3479

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Eleonora Cantoni (E)

Vita-Salute San Raffaele University, Milan, Italy.

Ivan Merelli (I)

San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
National Research Council, Institute for Biomedical Technologies, Segrate, Italy.

Davide Stefanoni (D)

Vita-Salute San Raffaele University, Milan, Italy.
Department of Biochemistry and Molecular Genetics, University of Colorado, Denver, Aurora, CO, USA.

Alessandro Tomelleri (A)

Vita-Salute San Raffaele University, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Corrado Campochiaro (C)

Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Vito Giordano (V)

Vita-Salute San Raffaele University, Milan, Italy.

Maddalena Panigada (M)

Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Elena M Baldissera (EM)

Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Laura Merlo Pich (L)

Vita-Salute San Raffaele University, Milan, Italy.

Valentina Natoli (V)

University of Genova and IRCCS G. Gaslini Institute, Genoa, Italy.

Athanasios Ziogas (A)

Department of Internal Medicine and Radboud Center for Infectious diseases (RCI), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.

Jorge Domínguez-Andrés (J)

Department of Internal Medicine and Radboud Center for Infectious diseases (RCI), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.

Giacomo De Luca (G)

Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Davide Mazza (D)

Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Samuel Zambrano (S)

Vita-Salute San Raffaele University, Milan, Italy.
Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Daniela Gnani (D)

Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Marina Ferrarini (M)

Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Elisabetta Ferrero (E)

Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alessandra Agresti (A)

Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Barbara Vergani (B)

Department of Pathology, Bicocca University, Milan, Italy.

Biagio Eugenio Leone (BE)

Department of Pathology, Bicocca University, Milan, Italy.

Simone Cenci (S)

Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Angelo Ravelli (A)

University of Genova and IRCCS G. Gaslini Institute, Genoa, Italy.

Marco Matucci-Cerinic (M)

Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Department Experimental and Clinical Medicine and Division of Rheumatology AOUC, University of Florence, Florence, Italy.

Angelo D'Alessandro (A)

Department of Biochemistry and Molecular Genetics, University of Colorado, Denver, Aurora, CO, USA.

Leo A B Joosten (LAB)

Department of Internal Medicine and Radboud Center for Infectious diseases (RCI), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Lorenzo Dagna (L)

Vita-Salute San Raffaele University, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Mihai G Netea (MG)

Department of Internal Medicine and Radboud Center for Infectious diseases (RCI), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.

Raffaella Molteni (R)

Vita-Salute San Raffaele University, Milan, Italy.
Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Giulio Cavalli (G)

Vita-Salute San Raffaele University, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH